NCT07540676

Brief Summary

In this single-center retrospective study, patients who underwent hip surgery between May 2025 and November 2025, with American Society of Anesthesiology (ASA) physical status I-III, aged 18 years and older, were screened. Patients who did not undergo a block for postoperative analgesia and who used patient-controlled analgesia were included in the control group. Patients who underwent QIPB and used patient-controlled analgesia were included in the block group. Patients' postoperative tramadol consumption, pain scores assessed using the Numerical Rating Scale, and rescue analgesia requirements were recorded. The primary endpoint was total opioid consumption over 24 hours, and the secondary endpoints were postoperative pain scores and rescue analgesia requirements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 9, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

March 9, 2026

Last Update Submit

April 14, 2026

Conditions

Hip Surgeries

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption

    Tramadol consumption in mg

    24 hours postoperatively

Secondary Outcomes (2)

  • Numeric Rating Scale

    base, 8., 6., and 24. hour postoperatively

  • The Need for Rescue Analgesics

    within 24 hours postoperatively

Study Arms (2)

Block Group

ACTIVE COMPARATOR
Drug: Quadro iliac Plane Block

Control Group

NO INTERVENTION

Interventions

Quadro iliac Plane BlockDRUG

Effectiveness in postoperative pain in hip surgeries

Block Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA score I-III
  • Underwent femoral intertrochanteric fracture or total hip replacement surgery

You may not qualify if:

  • neurological deficits
  • mental retardation
  • history of alcohol or substance use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goztepe Prof Dr Suleyman Yalci City Hospital

Istanbul, 34700, Turkey (Türkiye)

Location

Study Officials

  • Mesure G.N. Ozden, Ass Prof

    Goztepe Prof Dr Suleyman Yalcın City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 9, 2026

First Posted

April 20, 2026

Study Start

May 1, 2025

Primary Completion

October 30, 2025

Study Completion

November 30, 2025

Last Updated

April 20, 2026

Record last verified: 2026-04

Locations

TU(1)